Publicaciones en las que colabora con Maximino Redondo Bautista (17)

2012

  1. Clinical significance of langerhans cells in squamous cell carcinoma of the larynx

    Journal of Oncology

1998

  1. Dexamethasone induces altered binding of regulatory factors to HLA class I enhancer sequence in MCF-7 breast tumour cell line

    Cancer Immunology Immunotherapy, Vol. 46, Núm. 4, pp. 194-200

  2. Differential expression of MHC class II genes in lung tumour cell lines

    European Journal of Immunogenetics, Vol. 25, Núm. 6, pp. 385-391

  3. High incidence of H-ras mutations in laryngeal cancer in Spain

    Medical Science Research, Vol. 26, Núm. 4, pp. 279-281

1997

  1. Class I major histocompatibility complex antigens and tumor ploidy in breast and bronchogenic carcinomas

    Cancer Detection and Prevention, Vol. 21, Núm. 1, pp. 22-28

  2. Downmodulation of HLA class I expression by dexamethasone in MCF-7 cell line

    Journal of Physiology and Biochemistry, Vol. 53, Núm. 4, pp. 355-360

  3. Lack of correlation between codon 12 K-ras mutations and major histocompatibility complex antigens in bronchogenic carcinomas

    Cancer Detection and Prevention, Vol. 21, Núm. 5, pp. 412-417

1996

  1. MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: Long-term follow-up

    British Journal of Cancer, Vol. 74, Núm. 11, pp. 1801-1804

1991

  1. Altered HLA Class I Expression in Non-Small Cell Lung Cancer Is Independent of c-myc Activation

    Cancer Research, Vol. 51, Núm. 9, pp. 2463-2468

  2. Análisis de mutaciones en el codon 12 del oncogén H-RAS en el carcinoma epidermoide de laringe

    Análisis clínicos: órgano de expresión científica y profesional de la Asociación Española de Farmacéuticos Analistas, Tomo 16, Núm. 64, pp. 203-206

  3. Correlación entre expresión de anfígenos HLA y parámetros clínico-patológicos en el carcinoma broncogénico

    Neumosur: revista de la Asociación de Neumólogos del Sur, Vol. 3, Núm. 3, pp. 3-10

  4. Expression of HLA Class I and II Antigens in Bronchogenic Carcinomas: Its Relationship to Cellular DNA Content and Clinical-Pathological Parameters

    Cancer Research, Vol. 51, Núm. 18, pp. 4948-4954

  5. Molecular analysis of MHC‐class‐I alterations in human tumor cell lines

    International Journal of Cancer, Vol. 47, Núm. 6 S, pp. 123-130

1990

  1. K‐ras mutations (codon 12) are not involved in down‐regulation of mhc class‐i genes in colon carcinomas

    International Journal of Cancer, Vol. 46, Núm. 3, pp. 426-431

  2. Presence of hpv 16 sequences in laryngeal carcinomas

    International Journal of Cancer, Vol. 46, Núm. 1, pp. 8-11

  3. Valor pronóstico de la citometría de flujo del DNA en el carcinoma broncogénico

    Neumosur: revista de la Asociación de Neumólogos del Sur, Vol. 2, Núm. 2, pp. 9-13

1989

  1. MHC CLASS I AND II ANTIGENS ON GASTRIC CARCINOMAS AND AUTOLOGOUS MUCOSA

    International Journal of Immunogenetics, Vol. 16, Núm. 4-5, pp. 413-423